Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2
Tildrakizumab治疗伴有代谢综合征的银屑病患者的疗效和安全性：reSURFACE 1和reSURFACE 2研究5年数据的回顾性分析
期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.18167
Fernandez, A P; Dauden, E; Gerdes, S; Lebwohl, M G; Menter, M A; Leonardi, C L; Gooderham, M; Gebauer, K; Tada, Y; Lacour, J P; Bianchi, L; Egeberg, A; Pau-Charles, I; Mendelsohn, A M; Rozzo, S J; Mehta, N N
